Literature DB >> 2462601

T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.

J F Hoy1, J W Murphy, G G Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2462601     DOI： 10.1093/infdis/159.1.116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

1.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

Review 2.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

3.  Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein.

Authors:  M del Poeta; D L Toffaletti; T H Rude; S D Sparks; J Heitman; J R Perfect
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.

Authors:  S M Levitz; S Nong ; M K Mansour; C Huang; C A Specht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 5.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Authors:  Chao Huang; Shu-Hua Nong; Michael K Mansour; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Protective efficacy of antigenic fractions in mouse models of cryptococcosis.

Authors:  Michael K Mansour; Lauren E Yauch; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Isolation and purification of antigenic components of Cryptococcus.

Authors:  Karen L Wozniak; Stuart M Levitz
Journal:  Methods Mol Biol       Date:  2009

9.  Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.

Authors:  Christina C Chang; Andrew Lim; Saleha Omarjee; Stuart M Levitz; Bernadett I Gosnell; Tim Spelman; Julian H Elliott; William H Carr; Mohamed-Yunus S Moosa; Thumbi Ndung'u; Sharon R Lewin; Martyn A French
Journal:  J Infect Dis       Date:  2013-06-12       Impact factor: 5.226

10.  Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.

Authors:  C H Mody; R M Syme
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.